Question: What research is being done to test anti-etrovirals against Covid-19?

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: What studies on treatment and prevention of COVID-19 with antiretrovirals are being planned?
section_content: Several randomized trials are planned to assess the safety and efficacy of
using antiretroviral drugs – mainly LPV/r – for treating COVID-19, in
combination with other drugs. Results are expected from mid-2020 onwards.  

Reviewer feedback on this answer:
Mentions studies being planned to test antiretrovirals against coronavirus, and says results aren't available yet.
While this answer is vague, it addresses the original question asked.

Reviewer ratings:
Acceptable
Acceptable

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: Can antiretrovirals be used to treat COVID-19?
section_content: Several studies have suggested that patients infected with the virus causing
COVID-19, and the related coronavirus infections (SARS-CoV and MERS-CoV) had
good clinical outcomes, with almost all cases recovering fully. In some cases,
patients were given an antiretroviral drug: lopinavir boosted with ritonavir
(LPV/r). These studies were mostly carried out in HIV-negative individuals.
It is important to note that these studies using LPV/r had important
limitations. The studies were small, timing, duration and dosing for treatment
were varied and most patients received co-interventions/co-treatments which
may have contributed to the reported outcomes.
While the evidence of benefit of using antiretrovirals to treat coronavirus
infections is of very low certainty, serious side effects were rare. Among
people living with HIV, the routine use of LPV/r as treatment for HIV is
associated with several side effects of moderate severity. However, as the
duration of treatment in patients with coronavirus infections was generally
limited to a few weeks, these occurrences can be expected to be low or less
than that reported from routine use.

Reviewer feedback on this answer:
Describes several studies that looked at the efficacy of antiretrovirals against coronavirus.
This answer relates to the question and gives plenty of information.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: Can antiretrovirals be used to prevent COVID-19 infection?
section_content: Two studies have reported the use of LPV/r as post-exposure prophylaxis for
SARS-CoV and MERS-CoV. One of these studies suggested that the occurrence of
MERS-CoV infection was lower among health workers receiving LPV/r compared to
those who did not receive any drugs; the other study found no cases of SARS-
CoV infection among 19 people living with HIV hospitalized in the same ward of
SARS patients, of whom 11 were on antiretroviral therapy. Again, the certainty
of the evidence is very low due to small sample size, variability in drugs
provided, and uncertainty regarding intensity of exposure.  

Reviewer feedback on this answer:
Discusses studies of antiretrovirals for preventing infection with coronavirus among healthcare workers.
This answer does not talk about how anti-etrovirals are being tested for COVID-19, but does discuss different studies on COVID-19 treatments.

Reviewer ratings:
Excellent
Could be Improved